Search Results

Building on its unique six-year relationship with Avalon Ventures, GlaxoSmithKline will acquire San Diego-based Sitari Pharmaceuticals and its transglutaminase 2 small molecule program for celiac disease.

GSK to obtain transglutaminase 2 small molecule program for celiac disease

Janux Therapeutics, Inc. today announced the promotion of Dr. Tommy DiRaimondo to Chief Scientific Officer.

GSK has dropped two assets, an investigational celiac disease therapeutic and a Staphylococcus aureus vaccine hopeful, from its pipeline.

NeoGenomics, Inc. today announced the appointment of Elizabeth Floegel, Neil Gunn, and Tony Zook to its Board of Directors.

Palatin Technologies, Inc. announced that it has entered into a securities purchase agreement with institutional investors pursuant to which Palatin will issue and sell 8,100,000 shares of its Series B convertible redeemable preferred stock and 900,000 shares of its Series C convertible redeemable preferred stock to such investors.

The Arthritis National Research Foundation (ANRF) 2023 Research Scholar Symposium on March 11th, 8 AM - 5 PM at the Hyatt Regency Boston, offers attendees exposure to cutting-edge research they cannot find anywhere else.